Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Neha J. Pagidipati, Hillary Mulder et al.|Journal of the American College of Cardiology|2024Cited by 31